Importantly, both SNCA and LRRK2 have been associated with an increased risk of developing sporadic PD in a number of genome-wide association studies [17,18,19,20], suggesting that α-synuclein and LRRK2 play an important role in the pathogenesis of PD. Here, SNCA is linked to Parkinson disease.